Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



Talc Baby Powder Lawsuit: January 2025 Settlement Update

January 02, 2025
Recent updates on the ongoing Talc Baby Powder Lawsuit against Johnson & Johnson (JNJ) reveal progress towards a possible settlement. The lawsuit, which accuses the company's talc powder products of causing ovarian cancer, has been a widely debated topic in the legal and healthcare communities in recent years.
In January 2025, both Johnson & Johnson and the plaintiffs' attorneys announced that they have reached a tentative agreement for a settlement. While the details of the settlement are yet to be disclosed, it is speculated to be a substantial amount considering the number of individuals affected by the alleged side effect of the talc powder.
Johnson & Johnson has faced multiple lawsuits related to its talc products in the past. Despite the ongoing litigation, the company's stocks have remained resilient. In fact, during a time when the market has been facing a downturn, JNJ's stocks have been on an upward trajectory.
Investors have taken note of this positive trend and are eager to know what's next for Johnson & Johnson's talcum powder litigation. Experts recommend seeking professional advice from Stocks Prognosis regarding the forecast of JNJ's stock movement, as they have a proven track record in analyzing market trends.
While Johnson & Johnson has been working towards resolving the talc powder litigation, investors have been patiently waiting for a pullback in the company's stock. With the positive performance of JNJ in recent years, some investors believe that a potential pullback might present a buying opportunity.
Overall, the ongoing talc baby powder lawsuit settlement and the positive performance of Johnson & Johnson's stocks amidst a falling market have captured the attention of investors and legal observers alike. It remains to be seen what the final settlement will entail and how it will impact the company's future.
If you want to leave a comment, then you need Login or Register





Other data for JNJ

Related data

JNJJuly 14, 2025Johnson & Johnson Innovates with New Product Launches  ~1 min.

Johnson & Johnson, a leading pharmaceutical company, continues to make waves in the industry with its latest submission of sNDA for the schizophrenia drug CAPLYTA to the FDA....

JNJMay 25, 2025Revolutionary Innovation: JNJ Johnson & Johnson Leads the Medical Industry with Groundbreaking Technology  ~1 min.

Johnson & Johnson, the renowned medical technology company, continues to be at the forefront of innovation in the industry....

JNJMarch 21, 2025Johnson & Johnson Neurovascular leader heads for the exit  ~1 min.

Mark Dickinson, the leader of Johnson & Johnson Neurovascular, has announced his departure from the company....

JNJMarch 20, 2025Johnson & Johnson Faces Shareholder Activism Over Human Rights and Executive Pay Proposals  ~2 min.

Mark Dickinson, the leader of Johnson & Johnson Neurovascular, is leaving the company, according to sources....

JNJMarch 19, 2025FDA Clears Johnson & Johnson Robot for Enhanced Bronchoscopy  ~1 min.

Johnson & Johnson's MedTech division has received clearance from the FDA for its enhanced robotic-assisted bronchoscopy system....

JNJMarch 18, 2025Johnson & Johnson MedTech Introduces New EP Neurovascular Leader  ~1 min.

Johnson & Johnson MedTech, a subsidiary of Johnson & Johnson, has appointed a new leader for its electrophysiology and neurovascular group....

JNJMarch 14, 2025Johnson & Johnson's Decades-Long Quest for Effective IBD Treatments  ~1 min.

Johnson & Johnson has been investing in research and development for decades in order to find effective treatments for inflammatory bowel disease (IBD)....

JNJFebruary 28, 2025Johnson & Johnson's Strong Performance Since Last Earnings Report Raises Expectations  ~1 min.

Johnson & Johnson (JNJ) has shown an impressive 8.9% increase in its stock price since the release of its last earnings report....

JNJFebruary 26, 2025The surgical devices I design for JJ speed healing and save lives  ~1 min.

Johnson & Johnson (JNJ) has been at the forefront of medical technology, constantly innovating and developing breakthrough surgical devices that not only speed up the healing process but also save lives....

JNJFebruary 18, 2025Johnson & Johnson reportedly wants to sell Cerenovus for 1B  ~1 min.

According to recent reports, Johnson & Johnson is considering selling its Cerenovus stroke business for 1 billion dollars....

CNPJanuary 31, 2025CenterPoint Energy Inc. Reaches Settlement Agreement to Lower Bills for Customers in its 2024 Houston Electric Rate Case  ~2 min.

CenterPoint Energy Inc., a leading energy delivery company, has reached a settlement agreement with various parties to lower electric bills for customers in its 2024 Houston Electric Rate Case....

JNJJanuary 2, 2025Johnson & Johnson Settles Talc Baby Powder Lawsuit in January 2025  ~2 min.

Johnson & Johnson (JNJ) has recently reached a settlement in the longstanding talc powder ovarian cancer lawsuit....

IBMJanuary 6, 2025International Business Machines IBM Settles All Litigation Matters with GlobalFoundries  ~2 min.

International Business Machines Corporation (IBM) has reached a settlement agreement with GlobalFoundries, putting an end to all litigation matters between the two companies....

EDDecember 13, 2024Consolidated Edison ED Enters Forward Sale Agreement for 7 Million Common Shares  ~2 min.

Consolidated Edison, Inc. (NYSE: ED) has recently announced that it has entered into a forward sale agreement for 7 million of its common shares....

CVSDecember 22, 2024CVS Health Corporation Announces Settlement of $1.77 Billion Notes After Early Tender Offer  ~2 min.

CVS Health Corporation, a leading healthcare company, has announced the successful settlement of $1.77 billion in notes after an early tender offer....